Manchester Cancer Research Centre/mcrc.manchester.ac.uk
Apr 16, 2025, 07:43
Transforming melanoma treatment in Manchester – Manchester Cancer Research Centre
Manchester Cancer Research Centre shared a post on LinkedIn:
“Transforming melanoma treatment in Manchester.
Melanoma is the 5th most common cancer in the UK, but researchers in Manchester are transforming our understanding and treatment of the disease.
The CAcTUS clinical trial at The Christie NHS Foundation Trust is investigating how circulating tumour DNA (ctDNA) can be used to personalise treatment options for patients with advanced melanoma. By identifying the best time to switch between targeted therapy and immunotherapy, the trial hopes to improve patient outcomes and help optimise treatment strategies.
Learn more about the future of melanoma research in Manchester.
Click here to watch the video.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 13:05